Cargando…
Development of high-yield influenza A virus vaccine viruses
Vaccination is one of the most cost-effective ways to prevent infection. Influenza vaccines propagated in cultured cells are approved for use in humans, but their yields are often suboptimal. Here, we screened A/Puerto Rico/8/34 (PR8) virus mutant libraries to develop vaccine backbones (defined here...
Autores principales: | Ping, Jihui, Lopes, Tiago J.S., Nidom, Chairul A., Ghedin, Elodie, Macken, Catherine A., Fitch, Adam, Imai, Masaki, Maher, Eileen A., Neumann, Gabriele, Kawaoka, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569720/ https://www.ncbi.nlm.nih.gov/pubmed/26334134 http://dx.doi.org/10.1038/ncomms9148 |
Ejemplares similares
-
Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus
por: Taft, Andrew S., et al.
Publicado: (2015) -
Amino acid determinants conferring stable sialidase activity at low pH for H5N1 influenza A virus neuraminidase
por: Takahashi, Tadanobu, et al.
Publicado: (2012) -
Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses
por: Kiso, Maki, et al.
Publicado: (2010) -
Genetic characterization of H5N1 influenza viruses isolated from chickens in Indonesia in 2010
por: Nidom, Chairul A., et al.
Publicado: (2012) -
Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs
por: Guan, Lizheng, et al.
Publicado: (2023)